redalpine is a Swiss venture capital firm with over €1bn in assets under management that invests in European software and science companies. The firm operates from offices in Zurich and Berlin.
Portfolio
2
companies
AUM
£1000M
under management
Basecamp Research
Basecamp Research uses artificial intelligence to explore beyond known biology and solve life science challenges.
ExpressionEdits
ExpressionEdits uses artificial intelligence and proprietary intron technology to optimise protein expression.
Michael Sidler
Founding Partner
Singular led the Series B round, which will help fund data collection and foundational model development.
"We are pushing past AI’s limits in biological design by doubling down on solving the fundamental data gap that the entire biotech industry faces, Basecamp Research is using its technology to generate new and deeper insights, going beyond known biology and each day expand what we can offer to our partners in the biopharma ecosystem."
The seed round was co-led by Octopus Ventures and redalpine to support preclinical candidate selection and pipeline development.
"At ExpressionEdits, we’re revolutionizing gene expression by putting introns back where they belong, resulting in significant improvements in production"
